查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1595556

臨床前醫療設備測試服務市場：按服務、按階段分類 - 2025-2030 年全球預測

Preclinical Medical Device Testing Services Market by Service (Antimicrobial Activity Testing, Bioburden Determination, Biocompatibility Test), Phase (Antimicrobial Wound Dressings, Medical Coatings) - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 198 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

2023年臨床前醫療設備測試服務市值為65.4億美元，預計到2024年將達到73.4億美元，複合年成長率為12.66%，到2030年將達到150.7億美元，預計將達到1000萬美元。

臨床前醫療設備測試服務對於確保醫療設備在進入臨床試驗之前的安全性和有效性至關重要。這包括透過各種方法評估生物相容性、功能和性能，包括體外和體內測試。對這些服務的需求源於嚴格的監管合規要求以及減少與醫療設備故障相關的潛在風險的需要。臨床前測試的應用很廣泛，涵蓋植入設備、診斷設備和手術器械等設備類別。最終用途範圍主要包括醫療設備製造商、研究機構和熱衷於器材檢驗和安全保證的監管機構。市場成長的主要動力是創新醫療技術研發投資的增加、監管力度的加強以及需要先進醫療解決方案的慢性病盛行率的上升。此外，材料科學和生物標記技術的進步帶來了成長機會。然而，市場擴張面臨挑戰，例如與全面測試流程相關的高成本以及由於監管核准可能出現的延誤，這可能會拖累預算有限的中小型企業。此外，不斷變化的法規給市場相關人員帶來了合規挑戰。開發具有成本效益的調查方法以及整合人工智慧和機器學習以進行預測分析和高效試驗設計的機會比比皆是。此外，專注於穿戴式醫療設備等特定細分市場可提供巨大的成長潛力。為了利用這些機會，企業應優先投資最尖端科技，並加強與學術和研究機構的合作，以提高測試能力。儘管競爭激烈，但持續的創新和對技術進步的適應推動了市場的成功，使我們能夠有效應對複雜的法規環境，同時滿足日益成長的醫療設備測試需求。

主要市場統計
基準年[2023] 65.4億美元
預測年份 [2024] 73.4億美元
預測年份 [2030] 150.7億美元
複合年成長率（%） 12.66%

市場動態：快速發展的臨床前醫療設備測試服務市場的關鍵市場洞察

臨床前醫療設備測試服務市場正因供需的動態交互作用而轉變。透過了解這些不斷變化的市場動態，公司可以準備好做出明智的投資決策、完善策略決策並抓住新的商機。全面了解這些趨勢可以幫助企業降低政治、地理、技術、社會和經濟領域的風險，同時也能幫助企業了解消費行為及其對製造業的影響。

  • 市場促進因素
    • 對醫療設備驗證和檢驗的需求不斷增加
    • 政府對醫療基礎設施發展的積極努力和投資
    • 外包醫療設備檢測服務需求快速成長
  • 市場限制因素
    • 有限的基礎設施和複雜的服務
  • 市場機會
    • 物聯網和人工智慧在各種醫療設備中的發展
    • 醫療設備檢測服務的技術進步與創新
  • 市場挑戰
    • 對海外標準化資格考試的擔憂

波特五力：駕馭臨床前醫療設備測試服務市場的策略工具

波特的五力框架是了解市場競爭格局的重要工具。波特的五力框架為評估公司的競爭地位和探索策略機會提供了清晰的方法。該框架可幫助公司評估市場動態並確定新業務的盈利。這些見解使公司能夠利用自己的優勢，解決弱點並避免潛在的挑戰，從而確保更強大的市場地位。

PESTLE分析：了解臨床前醫療設備測試服務市場的外部影響

外部宏觀環境因素在塑造臨床前醫療設備測試服務市場的績效動態方面發揮著至關重要的作用。對政治、經濟、社會、技術、法律和環境因素的分析提供了應對這些影響所需的資訊。透過調查 PESTLE 因素，公司可以更了解潛在的風險和機會。這種分析可以幫助公司預測法規、消費者偏好和經濟趨勢的變化，並為他們做出積極主動的決策做好準備。

市場佔有率分析 了解臨床前醫療設備測試服務市場的競爭格局

臨床前醫療設備測試服務市場的詳細市場佔有率分析可以對供應商績效進行全面評估。公司可以透過比較收益、客戶群和成長率等關鍵指標來揭示其競爭地位。該分析揭示了市場集中、分散和整合的趨勢，為供應商提供了製定策略決策所需的洞察力，使他們能夠在日益激烈的競爭中佔有一席之地。

FPNV 定位矩陣臨床前醫療設備測試服務市場供應商的績效評估

FPNV 定位矩陣是評估臨床前醫療設備測試服務市場供應商的關鍵工具。此矩陣允許業務組織根據供應商的商務策略和產品滿意度評估供應商，從而做出符合其目標的明智決策。這四個象限使您能夠清晰、準確地分類供應商，以確定最能滿足您的策略目標的合作夥伴和解決方案。

策略分析和建議描繪了臨床前醫療設備測試服務市場的成功之路

對於旨在加強其在全球市場的影響力的公司來說，臨床前醫療設備測試服務市場的策略分析至關重要。透過考慮關鍵資源、能力和績效指標，公司可以識別成長機會並努力改進。這種方法使您能夠克服競爭環境中的挑戰，利用新的商機並取得長期成功。

本報告對市場進行了全面分析，涵蓋關鍵重點領域：

1. 市場滲透率：對當前市場環境的詳細審查、主要企業的廣泛資料、對其在市場中的影響力和整體影響力的評估。

2. 市場開拓：辨識新興市場的成長機會，評估現有領域的擴張潛力，並提供未來成長的策略藍圖。

3. 市場多元化：分析近期產品發布、開拓地區、關鍵產業進展、塑造市場的策略投資。

4. 競爭評估與情報：徹底分析競爭格局，檢驗市場佔有率、業務策略、產品系列、認證、監理核准、專利趨勢、主要企業的技術進步等。

5. 產品開發與創新：重點在於有望推動未來市場成長的最尖端科技、研發活動和產品創新。

我們也回答重要問題，以幫助相關人員做出明智的決策：

1.目前的市場規模和未來的成長預測是多少？

2. 哪些產品、區隔市場和地區提供最佳投資機會？

3.塑造市場的主要技術趨勢和監管影響是什麼？

4.主要廠商的市場佔有率和競爭地位如何？

5. 推動供應商市場進入和退出策略的收益來源和策略機會是什麼？

目錄

第1章 前言

第2章調查方法

第3章執行摘要

第4章市場概況

第5章市場洞察

  • 市場動態
    • 促進因素
      • 對醫療設備檢驗和檢驗的需求不斷增加
      • 政府對醫療基礎設施發展的有利措施和投資
      • 醫療設備檢測服務外包需求快速成長
    • 抑制因素
      • 基礎設施設置有限且服務複雜
    • 機會
      • IoT/AI在各種醫療設備中的發展
      • 醫療設備檢測服務的技術進步與創新
    • 任務
      • 海外統一資格考試的擔憂
  • 市場區隔分析
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 經濟
    • 社群
    • 技術的
    • 合法地
    • 環境

第6章臨床前醫療設備測試服務市場：依服務分類

  • 抗菌活性測試
  • 微生物附著量測量
  • 生物相容性測試
  • 化學測試
  • 微生物測試和無菌
  • 熱原和內毒素檢測
  • 無菌測試和檢驗

第7章臨床前醫療設備檢測服務市場分階段

  • 抗菌傷口敷料
  • 醫用塗層

第8章美洲臨床前醫療設備測試服務市場

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第9章亞太地區臨床前醫療設備測試服務市場

  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國
  • 越南

第10章歐洲、中東和非洲臨床前醫療設備測試服務市場

  • 丹麥
  • 埃及
  • 芬蘭
  • 法國
  • 德國
  • 以色列
  • 義大利
  • 荷蘭
  • 奈及利亞
  • 挪威
  • 波蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公國
  • 英國

第11章競爭格局

  • 2023 年市場佔有率分析
  • FPNV 定位矩陣，2023
  • 競爭情境分析
  • 戰略分析和建議

公司名單

  • Bureau Veritas SA
  • Charles River Laboratories, Inc.
  • Eurofins Scientific（Ireland）Limited
  • Intertek Group PLC
  • Medistri SA
  • Nelson Labs NV
  • PaxeraHealth LLC
  • Pharmacology Discovery Services Taiwan, Ltd.
  • SGS Societe Generale de Surveillance SA
  • Sipra Labs Limited
  • Sterigenics International LLC
  • TUV Rheinland AG
  • UL LLC
  • Viroclinics Biosciences
  • WuXi AppTec Co., Ltd.
Product Code: MRR-3A2E844FD678

The Preclinical Medical Device Testing Services Market was valued at USD 6.54 billion in 2023, expected to reach USD 7.34 billion in 2024, and is projected to grow at a CAGR of 12.66%, to USD 15.07 billion by 2030.

Preclinical medical device testing services are critical in ensuring the safety and efficacy of medical devices before they reach clinical trials. This involves assessments of biocompatibility, functionality, and performance through various methods such as in vitro and in vivo studies. The necessity of these services stems from the demand for stringent regulatory compliance and the need to mitigate potential risks associated with medical device failures. Applications of preclinical testing are wide-ranging, covering device categories like implantable devices, diagnostic equipment, and surgical instruments. The end-use scope primarily includes medical device manufacturers, research institutions, and regulatory bodies keen on device validation and safety assurance. Market growth is primarily driven by increasing R&D investments in innovative medical technologies, heightened regulatory scrutiny, and the rising prevalence of chronic diseases that necessitate advanced medical solutions. Moreover, advances in materials science and biomarker technologies present lucrative opportunities for growth. However, market expansion faces challenges such as high costs associated with comprehensive testing processes and potential delays due to regulatory approvals, which can deter smaller companies with budget constraints. Additionally, evolving regulations pose a compliance challenge for market players. Opportunities abound in the development of cost-effective testing methodologies and the integration of AI and machine learning for predictive analytics and efficient test designs. Moreover, focusing on specific segments like wearable medical devices can provide substantial growth potential. To capitalize on these opportunities, companies should prioritize investing in cutting-edge technologies and foster collaborations with academic and research institutions to enhance testing capabilities. Despite the competitive landscape, continuous innovation and adaptation to technological advancements will likely drive market success, positioning companies to effectively navigate the complexities of regulatory environments while meeting growing demands for medical device testing.

KEY MARKET STATISTICS
Base Year [2023] USD 6.54 billion
Estimated Year [2024] USD 7.34 billion
Forecast Year [2030] USD 15.07 billion
CAGR (%) 12.66%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Preclinical Medical Device Testing Services Market

The Preclinical Medical Device Testing Services Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Increasing need for validation and verification of medical devices
    • Favorable government initiatives and investments to develop healthcare infrastructure
    • Rapid demand for outsourcing medical device testing services
  • Market Restraints
    • Limited infrastructural setup and complex services
  • Market Opportunities
    • Development in IoT and AI in various medical devices
    • Technological advancements and innovations in medical device testing services
  • Market Challenges
    • Concerns regarding standardized overseas qualification tests

Porter's Five Forces: A Strategic Tool for Navigating the Preclinical Medical Device Testing Services Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Preclinical Medical Device Testing Services Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Preclinical Medical Device Testing Services Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Preclinical Medical Device Testing Services Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Preclinical Medical Device Testing Services Market

A detailed market share analysis in the Preclinical Medical Device Testing Services Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Preclinical Medical Device Testing Services Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Preclinical Medical Device Testing Services Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Preclinical Medical Device Testing Services Market

A strategic analysis of the Preclinical Medical Device Testing Services Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Preclinical Medical Device Testing Services Market, highlighting leading vendors and their innovative profiles. These include Bureau Veritas S.A., Charles River Laboratories, Inc., Eurofins Scientific (Ireland) Limited, Intertek Group PLC, Medistri SA, Nelson Labs NV, PaxeraHealth LLC, Pharmacology Discovery Services Taiwan, Ltd., SGS Societe Generale de Surveillance SA, Sipra Labs Limited, Sterigenics International LLC, TUV Rheinland AG, UL LLC, Viroclinics Biosciences, and WuXi AppTec Co., Ltd..

Market Segmentation & Coverage

This research report categorizes the Preclinical Medical Device Testing Services Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Service, market is studied across Antimicrobial Activity Testing, Bioburden Determination, Biocompatibility Test, Chemistry Test, Microbiology Test & Sterility, Pyrogen & Endotoxin Testing, and Sterility Test & Validation.
  • Based on Phase, market is studied across Antimicrobial Wound Dressings and Medical Coatings.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Increasing need for validation and verification of medical devices
      • 5.1.1.2. Favorable government initiatives and investments to develop healthcare infrastructure
      • 5.1.1.3. Rapid demand for outsourcing medical device testing services
    • 5.1.2. Restraints
      • 5.1.2.1. Limited infrastructural setup and complex services
    • 5.1.3. Opportunities
      • 5.1.3.1. Development in IoT and AI in various medical devices
      • 5.1.3.2. Technological advancements and innovations in medical device testing services
    • 5.1.4. Challenges
      • 5.1.4.1. Concerns regarding standardized overseas qualification tests
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Preclinical Medical Device Testing Services Market, by Service

  • 6.1. Introduction
  • 6.2. Antimicrobial Activity Testing
  • 6.3. Bioburden Determination
  • 6.4. Biocompatibility Test
  • 6.5. Chemistry Test
  • 6.6. Microbiology Test & Sterility
  • 6.7. Pyrogen & Endotoxin Testing
  • 6.8. Sterility Test & Validation

7. Preclinical Medical Device Testing Services Market, by Phase

  • 7.1. Introduction
  • 7.2. Antimicrobial Wound Dressings
  • 7.3. Medical Coatings

8. Americas Preclinical Medical Device Testing Services Market

  • 8.1. Introduction
  • 8.2. Argentina
  • 8.3. Brazil
  • 8.4. Canada
  • 8.5. Mexico
  • 8.6. United States

9. Asia-Pacific Preclinical Medical Device Testing Services Market

  • 9.1. Introduction
  • 9.2. Australia
  • 9.3. China
  • 9.4. India
  • 9.5. Indonesia
  • 9.6. Japan
  • 9.7. Malaysia
  • 9.8. Philippines
  • 9.9. Singapore
  • 9.10. South Korea
  • 9.11. Taiwan
  • 9.12. Thailand
  • 9.13. Vietnam

10. Europe, Middle East & Africa Preclinical Medical Device Testing Services Market

  • 10.1. Introduction
  • 10.2. Denmark
  • 10.3. Egypt
  • 10.4. Finland
  • 10.5. France
  • 10.6. Germany
  • 10.7. Israel
  • 10.8. Italy
  • 10.9. Netherlands
  • 10.10. Nigeria
  • 10.11. Norway
  • 10.12. Poland
  • 10.13. Qatar
  • 10.14. Russia
  • 10.15. Saudi Arabia
  • 10.16. South Africa
  • 10.17. Spain
  • 10.18. Sweden
  • 10.19. Switzerland
  • 10.20. Turkey
  • 10.21. United Arab Emirates
  • 10.22. United Kingdom

11. Competitive Landscape

  • 11.1. Market Share Analysis, 2023
  • 11.2. FPNV Positioning Matrix, 2023
  • 11.3. Competitive Scenario Analysis
  • 11.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Bureau Veritas S.A.
  • 2. Charles River Laboratories, Inc.
  • 3. Eurofins Scientific (Ireland) Limited
  • 4. Intertek Group PLC
  • 5. Medistri SA
  • 6. Nelson Labs NV
  • 7. PaxeraHealth LLC
  • 8. Pharmacology Discovery Services Taiwan, Ltd.
  • 9. SGS Societe Generale de Surveillance SA
  • 10. Sipra Labs Limited
  • 11. Sterigenics International LLC
  • 12. TUV Rheinland AG
  • 13. UL LLC
  • 14. Viroclinics Biosciences
  • 15. WuXi AppTec Co., Ltd.

LIST OF FIGURES

  • FIGURE 1. PRECLINICAL MEDICAL DEVICE TESTING SERVICES MARKET RESEARCH PROCESS
  • FIGURE 2. PRECLINICAL MEDICAL DEVICE TESTING SERVICES MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL PRECLINICAL MEDICAL DEVICE TESTING SERVICES MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL PRECLINICAL MEDICAL DEVICE TESTING SERVICES MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL PRECLINICAL MEDICAL DEVICE TESTING SERVICES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL PRECLINICAL MEDICAL DEVICE TESTING SERVICES MARKET SIZE, BY SERVICE, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL PRECLINICAL MEDICAL DEVICE TESTING SERVICES MARKET SIZE, BY SERVICE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL PRECLINICAL MEDICAL DEVICE TESTING SERVICES MARKET SIZE, BY PHASE, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL PRECLINICAL MEDICAL DEVICE TESTING SERVICES MARKET SIZE, BY PHASE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. AMERICAS PRECLINICAL MEDICAL DEVICE TESTING SERVICES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 11. AMERICAS PRECLINICAL MEDICAL DEVICE TESTING SERVICES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. UNITED STATES PRECLINICAL MEDICAL DEVICE TESTING SERVICES MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 13. UNITED STATES PRECLINICAL MEDICAL DEVICE TESTING SERVICES MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. ASIA-PACIFIC PRECLINICAL MEDICAL DEVICE TESTING SERVICES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 15. ASIA-PACIFIC PRECLINICAL MEDICAL DEVICE TESTING SERVICES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. EUROPE, MIDDLE EAST & AFRICA PRECLINICAL MEDICAL DEVICE TESTING SERVICES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 17. EUROPE, MIDDLE EAST & AFRICA PRECLINICAL MEDICAL DEVICE TESTING SERVICES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. PRECLINICAL MEDICAL DEVICE TESTING SERVICES MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 19. PRECLINICAL MEDICAL DEVICE TESTING SERVICES MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. PRECLINICAL MEDICAL DEVICE TESTING SERVICES MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL PRECLINICAL MEDICAL DEVICE TESTING SERVICES MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL PRECLINICAL MEDICAL DEVICE TESTING SERVICES MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL PRECLINICAL MEDICAL DEVICE TESTING SERVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. PRECLINICAL MEDICAL DEVICE TESTING SERVICES MARKET DYNAMICS
  • TABLE 7. GLOBAL PRECLINICAL MEDICAL DEVICE TESTING SERVICES MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL PRECLINICAL MEDICAL DEVICE TESTING SERVICES MARKET SIZE, BY ANTIMICROBIAL ACTIVITY TESTING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL PRECLINICAL MEDICAL DEVICE TESTING SERVICES MARKET SIZE, BY BIOBURDEN DETERMINATION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL PRECLINICAL MEDICAL DEVICE TESTING SERVICES MARKET SIZE, BY BIOCOMPATIBILITY TEST, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL PRECLINICAL MEDICAL DEVICE TESTING SERVICES MARKET SIZE, BY CHEMISTRY TEST, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL PRECLINICAL MEDICAL DEVICE TESTING SERVICES MARKET SIZE, BY MICROBIOLOGY TEST & STERILITY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL PRECLINICAL MEDICAL DEVICE TESTING SERVICES MARKET SIZE, BY PYROGEN & ENDOTOXIN TESTING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL PRECLINICAL MEDICAL DEVICE TESTING SERVICES MARKET SIZE, BY STERILITY TEST & VALIDATION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL PRECLINICAL MEDICAL DEVICE TESTING SERVICES MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL PRECLINICAL MEDICAL DEVICE TESTING SERVICES MARKET SIZE, BY ANTIMICROBIAL WOUND DRESSINGS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL PRECLINICAL MEDICAL DEVICE TESTING SERVICES MARKET SIZE, BY MEDICAL COATINGS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. AMERICAS PRECLINICAL MEDICAL DEVICE TESTING SERVICES MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 19. AMERICAS PRECLINICAL MEDICAL DEVICE TESTING SERVICES MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
  • TABLE 20. AMERICAS PRECLINICAL MEDICAL DEVICE TESTING SERVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 21. ARGENTINA PRECLINICAL MEDICAL DEVICE TESTING SERVICES MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 22. ARGENTINA PRECLINICAL MEDICAL DEVICE TESTING SERVICES MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
  • TABLE 23. BRAZIL PRECLINICAL MEDICAL DEVICE TESTING SERVICES MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 24. BRAZIL PRECLINICAL MEDICAL DEVICE TESTING SERVICES MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
  • TABLE 25. CANADA PRECLINICAL MEDICAL DEVICE TESTING SERVICES MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 26. CANADA PRECLINICAL MEDICAL DEVICE TESTING SERVICES MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
  • TABLE 27. MEXICO PRECLINICAL MEDICAL DEVICE TESTING SERVICES MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 28. MEXICO PRECLINICAL MEDICAL DEVICE TESTING SERVICES MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
  • TABLE 29. UNITED STATES PRECLINICAL MEDICAL DEVICE TESTING SERVICES MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 30. UNITED STATES PRECLINICAL MEDICAL DEVICE TESTING SERVICES MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
  • TABLE 31. UNITED STATES PRECLINICAL MEDICAL DEVICE TESTING SERVICES MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 32. ASIA-PACIFIC PRECLINICAL MEDICAL DEVICE TESTING SERVICES MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 33. ASIA-PACIFIC PRECLINICAL MEDICAL DEVICE TESTING SERVICES MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
  • TABLE 34. ASIA-PACIFIC PRECLINICAL MEDICAL DEVICE TESTING SERVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 35. AUSTRALIA PRECLINICAL MEDICAL DEVICE TESTING SERVICES MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 36. AUSTRALIA PRECLINICAL MEDICAL DEVICE TESTING SERVICES MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
  • TABLE 37. CHINA PRECLINICAL MEDICAL DEVICE TESTING SERVICES MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 38. CHINA PRECLINICAL MEDICAL DEVICE TESTING SERVICES MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
  • TABLE 39. INDIA PRECLINICAL MEDICAL DEVICE TESTING SERVICES MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 40. INDIA PRECLINICAL MEDICAL DEVICE TESTING SERVICES MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
  • TABLE 41. INDONESIA PRECLINICAL MEDICAL DEVICE TESTING SERVICES MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 42. INDONESIA PRECLINICAL MEDICAL DEVICE TESTING SERVICES MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
  • TABLE 43. JAPAN PRECLINICAL MEDICAL DEVICE TESTING SERVICES MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 44. JAPAN PRECLINICAL MEDICAL DEVICE TESTING SERVICES MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
  • TABLE 45. MALAYSIA PRECLINICAL MEDICAL DEVICE TESTING SERVICES MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 46. MALAYSIA PRECLINICAL MEDICAL DEVICE TESTING SERVICES MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
  • TABLE 47. PHILIPPINES PRECLINICAL MEDICAL DEVICE TESTING SERVICES MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 48. PHILIPPINES PRECLINICAL MEDICAL DEVICE TESTING SERVICES MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
  • TABLE 49. SINGAPORE PRECLINICAL MEDICAL DEVICE TESTING SERVICES MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 50. SINGAPORE PRECLINICAL MEDICAL DEVICE TESTING SERVICES MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
  • TABLE 51. SOUTH KOREA PRECLINICAL MEDICAL DEVICE TESTING SERVICES MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 52. SOUTH KOREA PRECLINICAL MEDICAL DEVICE TESTING SERVICES MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
  • TABLE 53. TAIWAN PRECLINICAL MEDICAL DEVICE TESTING SERVICES MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 54. TAIWAN PRECLINICAL MEDICAL DEVICE TESTING SERVICES MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
  • TABLE 55. THAILAND PRECLINICAL MEDICAL DEVICE TESTING SERVICES MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 56. THAILAND PRECLINICAL MEDICAL DEVICE TESTING SERVICES MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
  • TABLE 57. VIETNAM PRECLINICAL MEDICAL DEVICE TESTING SERVICES MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 58. VIETNAM PRECLINICAL MEDICAL DEVICE TESTING SERVICES MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
  • TABLE 59. EUROPE, MIDDLE EAST & AFRICA PRECLINICAL MEDICAL DEVICE TESTING SERVICES MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 60. EUROPE, MIDDLE EAST & AFRICA PRECLINICAL MEDICAL DEVICE TESTING SERVICES MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
  • TABLE 61. EUROPE, MIDDLE EAST & AFRICA PRECLINICAL MEDICAL DEVICE TESTING SERVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 62. DENMARK PRECLINICAL MEDICAL DEVICE TESTING SERVICES MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 63. DENMARK PRECLINICAL MEDICAL DEVICE TESTING SERVICES MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
  • TABLE 64. EGYPT PRECLINICAL MEDICAL DEVICE TESTING SERVICES MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 65. EGYPT PRECLINICAL MEDICAL DEVICE TESTING SERVICES MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
  • TABLE 66. FINLAND PRECLINICAL MEDICAL DEVICE TESTING SERVICES MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 67. FINLAND PRECLINICAL MEDICAL DEVICE TESTING SERVICES MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
  • TABLE 68. FRANCE PRECLINICAL MEDICAL DEVICE TESTING SERVICES MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 69. FRANCE PRECLINICAL MEDICAL DEVICE TESTING SERVICES MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
  • TABLE 70. GERMANY PRECLINICAL MEDICAL DEVICE TESTING SERVICES MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 71. GERMANY PRECLINICAL MEDICAL DEVICE TESTING SERVICES MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
  • TABLE 72. ISRAEL PRECLINICAL MEDICAL DEVICE TESTING SERVICES MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 73. ISRAEL PRECLINICAL MEDICAL DEVICE TESTING SERVICES MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
  • TABLE 74. ITALY PRECLINICAL MEDICAL DEVICE TESTING SERVICES MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 75. ITALY PRECLINICAL MEDICAL DEVICE TESTING SERVICES MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
  • TABLE 76. NETHERLANDS PRECLINICAL MEDICAL DEVICE TESTING SERVICES MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 77. NETHERLANDS PRECLINICAL MEDICAL DEVICE TESTING SERVICES MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
  • TABLE 78. NIGERIA PRECLINICAL MEDICAL DEVICE TESTING SERVICES MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 79. NIGERIA PRECLINICAL MEDICAL DEVICE TESTING SERVICES MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
  • TABLE 80. NORWAY PRECLINICAL MEDICAL DEVICE TESTING SERVICES MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 81. NORWAY PRECLINICAL MEDICAL DEVICE TESTING SERVICES MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
  • TABLE 82. POLAND PRECLINICAL MEDICAL DEVICE TESTING SERVICES MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 83. POLAND PRECLINICAL MEDICAL DEVICE TESTING SERVICES MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
  • TABLE 84. QATAR PRECLINICAL MEDICAL DEVICE TESTING SERVICES MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 85. QATAR PRECLINICAL MEDICAL DEVICE TESTING SERVICES MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
  • TABLE 86. RUSSIA PRECLINICAL MEDICAL DEVICE TESTING SERVICES MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 87. RUSSIA PRECLINICAL MEDICAL DEVICE TESTING SERVICES MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
  • TABLE 88. SAUDI ARABIA PRECLINICAL MEDICAL DEVICE TESTING SERVICES MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 89. SAUDI ARABIA PRECLINICAL MEDICAL DEVICE TESTING SERVICES MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
  • TABLE 90. SOUTH AFRICA PRECLINICAL MEDICAL DEVICE TESTING SERVICES MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 91. SOUTH AFRICA PRECLINICAL MEDICAL DEVICE TESTING SERVICES MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
  • TABLE 92. SPAIN PRECLINICAL MEDICAL DEVICE TESTING SERVICES MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 93. SPAIN PRECLINICAL MEDICAL DEVICE TESTING SERVICES MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
  • TABLE 94. SWEDEN PRECLINICAL MEDICAL DEVICE TESTING SERVICES MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 95. SWEDEN PRECLINICAL MEDICAL DEVICE TESTING SERVICES MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
  • TABLE 96. SWITZERLAND PRECLINICAL MEDICAL DEVICE TESTING SERVICES MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 97. SWITZERLAND PRECLINICAL MEDICAL DEVICE TESTING SERVICES MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
  • TABLE 98. TURKEY PRECLINICAL MEDICAL DEVICE TESTING SERVICES MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 99. TURKEY PRECLINICAL MEDICAL DEVICE TESTING SERVICES MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
  • TABLE 100. UNITED ARAB EMIRATES PRECLINICAL MEDICAL DEVICE TESTING SERVICES MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 101. UNITED ARAB EMIRATES PRECLINICAL MEDICAL DEVICE TESTING SERVICES MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
  • TABLE 102. UNITED KINGDOM PRECLINICAL MEDICAL DEVICE TESTING SERVICES MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 103. UNITED KINGDOM PRECLINICAL MEDICAL DEVICE TESTING SERVICES MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
  • TABLE 104. PRECLINICAL MEDICAL DEVICE TESTING SERVICES MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 105. PRECLINICAL MEDICAL DEVICE TESTING SERVICES MARKET, FPNV POSITIONING MATRIX, 2023